Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

It is known that microRNAs (miRNAs) are able to dynamically regulate gene expression. At the same time, methylation can reduce expression of miRNA encoding genes and, therefore, reduce their inhibitory effects on mRNAs of target genes, including those of oncogenes, that promoting the development of tumors of different localization. The role of miRNA hypermethylation in the pathogenesis of ovarian cancer is not completely understood; so we conducted a search for new hypermethylated and potentially suppressor miRNA genes in ovarian tumors. Four new miRNA genes (MIR-107, MIR-130b, MIR-203a, MIR-1258) commonly hypermethylated (28‒52% ) in tumor tissues vs 4‒7% in paired histologically normal tissues, p < 0.01, were identified in a representative set of 54 ovarian cancer samples using methylation-specific PCR. It was shown that hypermethylation of MIR-130b, MIR-203a, and MIR-1258 genes is significantly (p ≤ 0.05) associated with metastasis of ovarian cancer. These results suggest the involvement of four miRNAs (miR-107, miR-130b, miR-203a, and miR-1258) and hypermethylation of their encoding genes in the pathogenesis of ovarian cancer.

Ключевые слова

Об авторах

V. Loginov

Institute of General Pathology and Pathophysiology; Research Center of Medical Genetics

Автор, ответственный за переписку.
Email: loginov7w@gmail.com
Россия, Moscowa, 125315; Moscow, 115478

A. Burdennyy

Institute of General Pathology and Pathophysiology

Email: eleonora10_45@mail.ru
Россия, Moscowa, 125315

E. Filippova

Institute of General Pathology and Pathophysiology

Email: eleonora10_45@mail.ru
Россия, Moscowa, 125315

I. Pronina

Institute of General Pathology and Pathophysiology

Email: eleonora10_45@mail.ru
Россия, Moscowa, 125315

T. Kazubskaya

Blokhin Russian Cancer Research Center

Email: eleonora10_45@mail.ru
Россия, Moscow, 115478

D. Kushlinsky

Blokhin Russian Cancer Research Center

Email: eleonora10_45@mail.ru
Россия, Moscow, 115478

V. Ermilova

Blokhin Russian Cancer Research Center

Email: eleonora10_45@mail.ru
Россия, Moscow, 115478

S. Rykov

State Research Institute for Genetics and Selection of Industrial Microorganisms,
Kurchatov Institute National Research Center

Email: eleonora10_45@mail.ru
Россия, Moscow, 117545

D. Khodyrev

State Research Institute for Genetics and Selection of Industrial Microorganisms,
Kurchatov Institute National Research Center; Federal Research Clinical Center of Specialized Types of Medical Care and Medical Technologies,
Federal Biomedical Agency of Russia

Email: eleonora10_45@mail.ru
Россия, Moscow, 117545; Moscow, 115682

E. Braga

Institute of General Pathology and Pathophysiology; Research Center of Medical Genetics

Автор, ответственный за переписку.
Email: eleonora10_45@mail.ru
Россия, Moscowa, 125315; Moscow, 115478

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Pleiades Publishing, Inc., 2018

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).